Supply Chain

Ashland, Missouri – October 02, 2026 -- ABK Biomedical Inc. has launched construction of a commercial-scale manufacturing facility at Cartwright Business Park in Ashland, Missouri, designed to produce its Eye90 microspheres for liver cancer treatment. The groundbreaking, attended by Missouri Governor Mike Kehoe, follows the company's April announcement selecting Ashland for its long-term U.S. manufacturing base.

Facility targets commercial-scale output of yttrium-90 radioembolization device

The planned Good Manufacturing Practice (GMP) facility will be built for commercial-scale production of Eye90 microspheres, a clinical-stage yttrium-90 radioembolization device still under development for liver cancer treatment. The devices remain investigational and are not approved for use outside authorized clinical trials.

San Francisco – October 02, 2026 -- Constructor, a product discovery platform for ecommerce, has won the "Agentic Achievement" category at the MACH Alliance's 2026 MACH Impact Awards, citing a 900% year-over-year increase in companies deploying its conversational AI agents.

Retailers report measurable gains from agent deployments

Across customer deployments, Constructor's agentic technology has driven a 57% reduction in support requests, more than double the conversion rate versus standard search, 52% higher add-to-cart rates and 56% higher purchase rates among shoppers using an agent, according to the company.

Burgettstown, Pa. – October 02, 2026 -- 6K Additive Inc. (ASX: 6KA) has executed a final US$27.4 million loan agreement with the Export-Import Bank of the United States (EXIM) to fund expansion of its critical materials manufacturing plant in Burgettstown, Pennsylvania.

EXIM finalizes largest Make More in America loan for advanced materials

The facility, approved by EXIM's board on December 4, 2025, is the first deal structured in coordination with the U.S. Department of War's Defense Production Act Title III initiative and the largest loan issued under EXIM's Make More in America Initiative (MMIA) for advanced materials and manufacturing to date.

Delray Beach – October 02, 2026 -- The global emulsifiers market is projected to climb to USD 18.15 billion by 2031, up from USD 12.15 billion in 2026, expanding at a compound annual growth rate of 8.4%, according to MarketsandMarkets.

Food applications drive demand as processed food consumption rises worldwide

Food emulsifiers are set to post the fastest growth within applications, at an 8.9% CAGR, as manufacturers use the ingredients to stabilize bakery goods, dairy products, margarine, sauces, and plant-based foods. Rising demand for low-fat, low-calorie, and clean-label products is pushing producers to rely on emulsifiers to maintain texture and shelf life without added fats or calories.

Vancouver – October 02, 2026 -- Trilogy Metals Inc. (NYSE American: TMQ; TSX: TMQ) closed a $17.8 million strategic equity investment from the United States Department of War (DOW) on September 11, 2026, as part of a broader $35.6 million financing package tied to its Upper Kobuk Mineral Projects (UKMP) in Alaska. The company reported a cash balance of $31.2 million and adjusted working capital of $30.3 million as of August 31, 2026, which it says substantially funds its share of Ambler Metals LLC's fiscal 2026 budget.

Delray Beach, Fla. – October 02, 2026 -- The global space sensors and actuators market is set to grow from $5.75 billion in 2026 to $9.04 billion by 2031, a 9.5% compound annual growth rate, according to a new report from MarketsandMarkets.

Sensors segment leads demand on satellite positioning and propulsion needs

By product type, sensors are estimated to lead the market, driven by their critical role in satellite positioning, propulsion control, and robotic operations. Manufacturers are advancing compact, radiation-hardened, and electromechanical sensor designs to serve both deep space and commercial missions.

Interplanetary spacecraft and probes dominate platform-level spending

The interplanetary spacecraft & probes segment is estimated to hold the largest market share by platform, as rising investment in planetary exploration missions fuels demand for advanced sensing and actuation systems.

New York – October 02, 2026 -- Roland Foods, LLC will acquire Savor Brands, LLC from Dot Foods, Inc. under a strategic partnership that also gives Dot Foods an equity interest in Roland Foods, the companies announced. The deal pairs Roland Foods' 2,400-product global ingredient portfolio with Savor's frozen offerings and expanded import range, while Dot Foods will distribute both Roland and Savor products through its nationwide less-than-truckload redistribution network.

Dot Foods gains equity stake while keeping distribution role

Dot Foods, which carries 130,000 products from 1,500 manufacturers and operates 13 U.S. distribution centers plus two in Canada, will become both a shareholder in Roland Foods and its commercial distribution partner. Keith Dougherty, CEO of Roland Foods, said the Dot relationship will make it easier for customers to buy from the combined business.

South San Francisco, Calif. – October 02, 2026 -- AKASA has launched an autonomous AI platform for inpatient medical coding and clinical documentation integrity (CDI), expanding beyond its existing prebill review tools after inpatient volume processed by the company grew nearly 6x over the past year.

AKASA's health system customers now cover 10% of U.S. inpatient discharges

The company's customer base collectively represents more than $180 billion in aggregate net patient revenue and roughly 10% of all U.S. inpatient discharges. The growth has been driven by adoption of AKASA's existing AI-powered prebill review products, which the company says created the volume and performance data needed to move into fully autonomous coding.

Geneva – October 02, 2026 -- The employee partnership owning Gunvor Group Ltd has voted to rename the company Centalion Group Ltd and relocate its corporate headquarters from Cyprus to Singapore, marking the next phase after a December 2025 management buyout.

Partnership referendum backs new brand after six-month review

The name change followed a full partnership referendum in July 2026, preceded by six months of employee engagement and market-positioning research conducted by brand specialist Landor. Gary Pedersen, Chairman and CEO of Centalion, said the move reflects "one team, moving together, at the heart of the global energy markets," framing it as a step taken from a position of commercial strength rather than necessity.

Nottingham, England – October 02, 2026 -- Quotient Sciences and Copenhagen-based Acesion Pharma have launched a collaboration to apply AI-enhanced formulation development to Acesion's early-stage pipeline of small molecules targeting atrial fibrillation, a condition affecting an estimated 50-60 million people globally.

AI tool uses Bayesian optimization to screen drug formulations for clinical success

The collaboration deploys Quotient Sciences' new AI-enhanced formulation development solution within its Translational Pharmaceutics platform, applying active machine learning with Bayesian optimization to identify and prioritize drug products most likely to succeed in clinical testing. The approach is designed to compress early clinical decision-making timelines for sponsors developing new treatments.